全文获取类型
| 收费全文 | 228712篇 |
| 免费 | 4355篇 |
| 国内免费 | 369篇 |
专业分类
| 耳鼻咽喉 | 1750篇 |
| 儿科学 | 8226篇 |
| 妇产科学 | 4595篇 |
| 基础医学 | 22105篇 |
| 口腔科学 | 3337篇 |
| 临床医学 | 16967篇 |
| 内科学 | 42062篇 |
| 皮肤病学 | 1702篇 |
| 神经病学 | 19295篇 |
| 特种医学 | 10780篇 |
| 外国民族医学 | 15篇 |
| 外科学 | 38633篇 |
| 综合类 | 3490篇 |
| 现状与发展 | 4篇 |
| 一般理论 | 39篇 |
| 预防医学 | 21823篇 |
| 眼科学 | 4583篇 |
| 药学 | 13865篇 |
| 1篇 | |
| 中国医学 | 1038篇 |
| 肿瘤学 | 19126篇 |
出版年
| 2023年 | 579篇 |
| 2022年 | 1434篇 |
| 2021年 | 2743篇 |
| 2020年 | 1605篇 |
| 2019年 | 2055篇 |
| 2018年 | 24123篇 |
| 2017年 | 18799篇 |
| 2016年 | 21053篇 |
| 2015年 | 2876篇 |
| 2014年 | 3375篇 |
| 2013年 | 3876篇 |
| 2012年 | 11497篇 |
| 2011年 | 25372篇 |
| 2010年 | 21194篇 |
| 2009年 | 13497篇 |
| 2008年 | 22481篇 |
| 2007年 | 24663篇 |
| 2006年 | 3462篇 |
| 2005年 | 4828篇 |
| 2004年 | 5732篇 |
| 2003年 | 6353篇 |
| 2002年 | 4253篇 |
| 2001年 | 795篇 |
| 2000年 | 845篇 |
| 1999年 | 562篇 |
| 1998年 | 484篇 |
| 1997年 | 417篇 |
| 1996年 | 305篇 |
| 1995年 | 276篇 |
| 1994年 | 255篇 |
| 1993年 | 189篇 |
| 1992年 | 236篇 |
| 1991年 | 300篇 |
| 1990年 | 309篇 |
| 1989年 | 251篇 |
| 1988年 | 208篇 |
| 1987年 | 183篇 |
| 1986年 | 160篇 |
| 1985年 | 190篇 |
| 1984年 | 139篇 |
| 1983年 | 114篇 |
| 1982年 | 116篇 |
| 1981年 | 84篇 |
| 1980年 | 103篇 |
| 1979年 | 64篇 |
| 1978年 | 72篇 |
| 1976年 | 62篇 |
| 1974年 | 71篇 |
| 1938年 | 63篇 |
| 1932年 | 57篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
31.
Tarandovskiy Ivan D. Rajabi Ali A. Karnaukhova Elena Buehler Paul W. 《Journal of thrombosis and thrombolysis》2019,48(1):81-87
Journal of Thrombosis and Thrombolysis - C1-inhibitor (C1INH) was shown to enhance thrombin generation (TG) in the presence of thrombomodulin (TM) by reducing production of activated protein C.... 相似文献
32.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献33.
34.
To determine the protective effect of aloe-emodin (AE) from high glucose induced toxicity in RIN-5F (pancreatic β-cell) cell and restoration of its function was analyzed. RIN-5F cells have been cultured in high glucose (25 mM glucose) condition, with and without AE treatment. RIN-5F cells cultured in high glucose decreased cell viability and increased ROS levels after 48 hr compared with standard medium (5.5 mM glucose). Glucotoxicity was confirmed by significantly increased ROS production, increased pro-inflammatory (IFN-γ, IL-1β,) & decreased anti-inflammatory (IL-6&IL-10) cytokine levels, increased DNA fragmentation. In addition, we found increased Bax, caspase 3, Fadd, and Fas and significantly reduced Bcl-2 expression after 48 hr. RIN-5F treated with both high glucose and AE (20 μM) decreased ROS generation and prevent RIN-5F cell from glucotoxicity. In addition, AE treated cells cultured in high glucose were transferred to standard medium, normal responsiveness to glucose was restored within 8hr and normal basal insulin release within 24 hr was achieved when compared to high glucose. 相似文献
35.
Effects of Paclitaxel and Carboplatin Combination on Mechanical Myocardial and Microvascular Functions: A Transthoracic Doppler Echocardiography and Two‐Dimensional Strain Imaging Study 
下载免费PDF全文
下载免费PDF全文 36.
37.
38.
Background and study aims
Acute upper gastrointestinal bleeding is one of the main causes of hospitalisation. The purpose of this study was to determine the prognostic factors in non-variceal upper gastrointestinal bleeding.Patients and methods
Clinical outcomes, demographic and laboratory variables of the subjects were collected from the HIS software and national code with the SQL format from three hospitals in Qazvin. The data were linked to the database software designed by the author. Clinical and upper endoscopic findings of patients’ records were collected through a questionnaire form in the designed software database.Results
In this study, 29.2% of patients with favourable outcome and 64.2% of patients with unfavourable clinical outcomes had a history of anticoagulant drug use before hospitalisation (p?<?0.001). The prevalence of chronic cardiovascular disease, chronic liver disease, chronic lung disease, diabetes and dialysis was higher in subjects with poor clinical outcomes than those with a favourable clinical outcome.53.1% of subjects with favourable clinical outcome and 90.5% of subjects with undesirable clinical outcomes received packed red blood cell transfusion (p?<?0.001). 16.1% of subjects with desirable clinical outcome and 86.3% of subjects with undesirable clinical outcomes received endoscopic haemostatic treatment which was statistically significant (p?<?0.001).Conclusion
Undesirable clinical outcome in patients with acute non-variceal upper gastrointestinal bleeding has a significant statistical association with longer hospitalisation, chronic underlying disease, anticoagulant administration, packed red blood cell infusion, higher Forrest stage, low systolic blood pressure, higher age, low haemoglobin, low platelet count, high INR and high BUN at the onset of diagnosis. 相似文献39.
40.